Doctor profile · Federal record
Dr. Amanda Marsch, M.D.
Dermatology Physician (CMS: Dermatology) · West Palm Beach, FL
- NPI 1295025476
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
701 Northpoint Parkway, Ste 300
West Palm Beach, FL 33407
(561) 863-1000 - Mailing address
-
Po Box 232410
San Diego, CA 92193
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- January 5, 2022
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #A136679
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295025476. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,082
Distinct HCPCS
10
Medicare allowed
$514,092
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,523 | 377 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,387 | 737 | $92 | |
11102 |
Biopsy of related skin growth, first growth | 976 | 625 | $96 | |
17000 |
Destruction of precancer skin growth, 1 growth | 821 | 514 | $44 | |
11103 |
Biopsy of related skin growth, each additional growth | 632 | 302 | $51 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 270 | 199 | $130 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 249 | 150 | $158 | |
17110 |
Destruction of skin growth, 1-14 growths | 214 | 183 | $112 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 209 | 209 | $115 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 141 | 115 | $58 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 236. This provider delivers 34× the peer median.Open Payments
Industry payments received
All-time total
$755
Transactions
42
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 19 | $178.68 | |
| GENZYME CORPORATION | 5 | $130.60 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $85.00 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $75.46 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $56.82 | |
| Novartis Pharmaceuticals Corporation | 2 | $46.36 | |
| Galderma Laboratories, L.P. | 2 | $39.03 | |
| Biofrontera Inc. | 2 | $37.47 | |
| Incyte Corporation | 2 | $33.77 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $31.68 | |
| Arcutis Biotherapeutics, Inc. | 1 | $22.00 | |
| LEO Pharma Inc. | 1 | $18.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,556
Patients
1,059
Total drug cost
$127,674
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 372 | 283 | $2,751 |
| Ketoconazole | Generic | 272 | 152 | $6,231 |
| Triamcinolone Acetonide | Generic | 190 | 142 | $3,208 |
| Clobetasol Propionate | Generic | 129 | 81 | $5,607 |
| Hydrocortisone | Generic | 117 | 81 | $832 |
| Doxycycline Hyclate | Generic | 116 | 80 | $2,713 |
| Fluorouracil | Generic | 75 | 69 | $6,612 |
| Fluocinonide | Generic | 61 | 52 | $3,256 |
| Ciclopirox | Generic | 60 | 36 | $2,121 |
| Betamethasone Dipropionate | Generic | 36 | 21 | $2,078 |
Frequently asked questions
What is Dr. Amanda Marsch's medical specialty?
Dr. Amanda Marsch practices Dermatology Physician in West Palm Beach, FL.
Where does Dr. Amanda Marsch practice?
Dr. Amanda Marsch practices at 701 Northpoint Parkway, West Palm Beach, FL 33407. Office phone: 5618631000.
What is Dr. Amanda Marsch's NPI?
Dr. Amanda Marsch's National Provider Identifier (NPI) is 1295025476, issued by NPPES.
Does Dr. Amanda Marsch accept Medicare assignment?
Yes. Dr. Amanda Marsch accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amanda Marsch commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.